Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arlzyme is a proprietary Ayurvedic digestive formulation developed by Arlak Ayurveda, available in both capsule and syrup forms. It is designed to manage gastrointestinal disorders such as dyspepsia (indigestion), flatulence, bloating, and chronic constipation. The formulation typically includes a blend of traditional herbs like *Zingiber officinale* (Ginger), *Carica papaya* (Papaya), *Trachyspermum ammi* (Ajwain), and *Piper longum* (Pippali), which work synergistically to stimulate endogenous digestive enzyme secretion, enhance nutrient absorption, and regulate bowel movements. As an Ayurvedic proprietary medicine, it is positioned as a natural alternative to synthetic digestive enzymes and is marketed as an over-the-counter (OTC) digestive tonic for both children and adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Arlzyme.